Back Matter (PDF)

Back Matter (PDF)

Guidelines for Submitting Disks to American Association for Cancer Research Publications The word processingpackagesthat we preferare as follows: MacWrite WordPerfect(DOS,Windows, Microsoft Word (DOS, Windows, and Macintosh) and Macintosh) XyWrite(DOSand Windows) Also acceptable: Ability Mass 11 SoloWriter AmiPro MS WindowsWrite Sprint AMS-T@X MS Works Stx Appleworks MS WorksWP Mac SunWrite ArborT@X Multimate Symphony ArborText Multimate Advantage TEX ClarisWorks WP Nibia T@X78 CPT8000 Nisus(to ASCIIfile) Text EXecutive CTOS Notewriter Textures Diablo Obun Total Word DisplayWnte OfficeWriter Troff Duet PC Write pT@X Einstein PFS First Choice Volkswriter Enable ProfessionalWrite VuWnter EXP Q&A Write Wang OIS FinalWord QuarkXPress WangWPS FullWrite RagTimeMS Works WangWriter GemWordPlus (to ASCIIfile) WindowWorks IBM Writing Assistant Rich Text Format Windows Write Interleaf RSG (to ASCII file) WiziWord LATEX Signature Wordstar Latex SLITEX Wordstar 2000 LeadingEdge SmartWhere WriteNow Lotus Manuscript SmartWriteII Xerox LotusWrite Software packages that we are unable to translate: FrameMaker Ready,Set, Go PageMaker ScientificWriter Disksproducedon IBMor IBM-compatiblecomputersarepreferred,but thoseproducedon someAppleor Wangcomputerscanalsobeconverted.Becauseof thefilestructuresandinternalcoding,wecannotaccept diskscreatedondesktoppublishingsystemsorthosecreatedonproprietarytypesettingsystems.Wealso cannot guarantee that all special characters can be translated. Tabular and mathematical material, such as equations, will not be captured from the disk but will be rekeyed. To expeditework and for yourown security,we do requirethat you submita hardcopy printoutof the disk file. Thetablesand equationswill be keyedfrom this hardcopy. Wealsoneedto knowthe nameof the file to be converted, the type of hardware (e.g., IBM PC) on which the files were created, the operating system (e.g.,DOS3.3),andtheversionof thesoftware(e.g.,WordPerfect5.1)usedto createthefile. PLEASE FILL OUT ALL INFORMATION ON REVERSE SIDE AND SUBMIT THIS FORM WITH YOUR DISK. DISKSWILLNOTBEPROCESSEDWITHOUTTHISINFORMATION. P DISKSUBMISSIONFORM AACR journals are now using personal computers to copyedft manuscilpts accepted for pubflcatlon. When submfttingarevisedmanuscript,authorsareencouragedto submftane@ctronIcd@kofthepaperakngwW@ the requiredfour hardcopyprintouts.DiskswhOultimatelybereturnedto the authors. I Seereverseforthewordprocessingpackagesthatcanbeaccepte@] File preparation Pleasebe sure that the file you send is the most recentver&onof the manuscriptand that It matchesthe mostrecentlysubmittedprintedcopy.Thefile shouldcontainallthe partsof the manuscriptin ons file, Mathernaficalandtabularmaterial,however,will beprocessedInthe tradtdOnalmannerandmaybeexduded fromthe diskfile. Note:AACRdoesnotassumeresponsibilityforerrorsinconversionof cUstOmiZedsoftware,newlyreleased software,or spedalcharacters. Pleaselabel the outside of the dIsk wfth the journal name,the first authot@sname,a parM tftle of the manuscript,andthe nameof the computerfile usedto accessthe manuscripton disk.To processyourdisk efflcielrn, we needthe [email protected] provideALL the information. Nameusedtoaccesspaperondisk:________________________________________ Nameofcomputerused(e.g.,IBM/PS2): Oprating systm and version (e.g., DOS 3.3): Word processIng program and version (e.g., WordPerfect 5.0): [See reverse for acceptable programs.] Manuscriptnumber@ riru auuiur; Corresponding author (If different from first author): Telephone/FAXnumbers: This form (both sides) may be reproduced. @ \@‘@\ @r AACR SPECIAL CONFERENCE IN CANCER RESEARCH NovelStrategiesAgainstResistantCancers /@%C@c' November17-21,1995 SanibelHarbourResortandSpa Ft.Myers,Florida CONFERENCECHAIRPERSONS DanielD.VonHoffI SanAntonio,TX VictorLingI Vancouver,BritishColumbia,Canada PROGRAM COMMIUEE DonaldS. CoffeyI Ba1@more,MD GertrudeB.EllonI ResearchThanglePark,NC Adrian L Harris I Oxford,England EvaV.LeeI SanAntonio,TX AllenI 011ffI WestPoint,TX JeffreyU.TrentI Bethesda,MD AlexanderW.WoodI Nutley,NJ SCIENTIFIC PROGRAM KeynoteAddress BiologyandClinicalTrialsInResistance DonaldS.CoffeyI Baltimore,MD MuitidrugResistanceProteins Met Borst I Amsterdam,TheNetherlands RecentlyDescribedTargets Susan P.C. Cole! Kingston,Ontario,Canada TelorneresandTebnerase KennethD.TewI Philadelphia,PA BradfordE@WindleI SanMtonio,TX ReversingDrugResistance Jerry W.Shay I Dalas, TX WilliamS. Dalton/Tucson, AZ Fanssyl Transferase Branimir L SIkic I StanfOrd,CA AllenI OliffI WestPo@t,PA AlexanderW.WoodI Nutley,NJ GeneManipulatingStrategies GlennDranoftI Cambridge,MA Blood Vessels and Microenvironment EvaY.Lie! SanAntonio,TX An@ AdrianL HarrisI Oxford,England S.GiMEckhwdtI SanAntonio,TX Summary VictorUngI Vancouver,BritishColumbia,Canada Strategies with Previously Described Daniel D. Von Hoff! San Mtonio, TX Targets AdditionalSpeakerstobeAnnounced TopoisomeraseIinhibitor YvesG.Pommlar!Bethesda,MD Applicantsare encouragedto submit Macs L Rothenbsrg I San Antonio, TX abstractsfor posterpresentation. Selectedprofferedpapers will also be Thym@ S@se Youcsfti RustumIBuffalo,NY scheduledfor oralpresentations. NeilJ. ClendeninnI San Diego,CA JamesL AbbruusaeIHouston,TX lisA Matterof Timing infonnation and Application Forms WilliamJi&.Hrush.sltyI ALany,NY AmericanAssociationforCancerResearch PublicLedgerBuilding,Suite816 150SouthIndependenceMail West Philadelphia, PA 19106-3483 215-440-9300 215-440-9313 (FAX) AACR SPECIALCONFERENCEIN CANCER RESEARCH CancerSusceptibilityGenesand @ MolecularCarcinogenesis @ The KeystoneRe@,Keyston:, Colorado CONFERENCECHAIRPERSONS AllanBalmainI Glasgow,Scotland CurtisC.HarrIsI Bethesda,MD KennethOldenI ResearchTrianglePark,NC SCIENTIFIC PROGRAM KeynoteAddress Apoptosis HaroldE.VarmusI Bethesda,MD TonaM.GIlmerI ResearchTrianglePark,NC JudithCampisiI Berkeley,CA GeneticSusceptibilityof Animal MichaelB.KastanI Baltimore,MD Models- InbredStrains EileenWhiteI Piscataway,NJ WIlliamF.DoveI Madison,WI ScottW.LoweI Cambridge,MA NormanA.DrlnkwaterI Madison,WI CherylLynWalkerI Smithville,TX MolecularCarcinogenesisinAnimal PeterDemantI Amsterdam,TheNetherlands ModelsandHumans- Skin AllanBalmaInI Glasgow,Scotland GeneticSusceptIbilityofAnimal DouglasE.BrashI NewHaven,CT Models- TransgenicandKnockout DouglasHanahanI SanFrancisco,CA MolecularCarclnogenesisIn AnimalModelsand TylerE.JacksI Cambridge,MA Humans- LiverandBreast MichaelP.RosenbergI ResearchTrianglePark,NC KennethOldenI ResearchTrianglePark,NC HenryC.PftotI Madison,WI GeneticSusceptlbilftyof Humans- XInW.WangI Bethesda,MD XenoblotlcMetabolism RogerW.WlsemanI ResearchThanglePark,NC FrankJ.GonzalezI Bethesda,MD Mary-ClaireKingI Seattle,WA FredF.KadlubarI Jefferson,AR PeterG.ShieldsI Bethesda,MD MolecularCarclnogeneslsinAnimalModelsand C. Roland Wolf I Dundee, Scotland Humans- Brain TerryA.VanDykeI ChapelHill,NC GeneticSusceptibilftyof Humans- PaulKleihuesILyon,France DNARepair IsabelMellonI Lexington,KY JanILHoeijmakersI Rotterdam,TheNetherlands Applicantsareencouragedto submit RichardD.KolodnerI Boston,MA abstractsforposterpresentation. GeneticSusceptlbilftyof Humans- Application deadline: November 3, 1995 TumorSuppressorGenes DavidP.LaneI Dundee,Scotland InformationandApplicationForms LouiseC.StrongI Houston,TX CurtisC.HarrisI Bethesda,MD American Association for Cancer Research RiChardD.KlausnerI Bethesda,MD Public Ledger Building, Suite 816 I 50 South Independence Mall West SenescenceandTerminalDifferentiation Philadelphia,PA 19106-3483 J.CarlBarrettI ResearchTrianglePark,NC 215-440-9300 215-440-9313 (FAX) JerryW.ShayI Datlas,TX JenniferA.PletenpolI Nashville,TN HaroldL MosesI Nashville,TN.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    4 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us